Latest news
Scholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Sat, 08 Aug 2026 02:32:33 GMTRecovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - medcitynews.commedcitynews.com · Fri, 07 Aug 2026 22:12:34 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA approves first-in-class drug to treat narcolepsy - Drug Discovery NewsDrug Discovery News · Fri, 07 Aug 2026 19:48:16 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMTEli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOXLiveNOW from FOX · Fri, 07 Aug 2026 15:20:40 GMTFDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMTFDA approves Orzeyful for narcolepsy type 1 in adults - American Academy of Sleep Medicine | AASMAmerican Academy of Sleep Medicine | AASM · Fri, 07 Aug 2026 14:23:12 GMT